We at UCSF take your care seriously. Click here for COVID-19 information

University of California San Francisco

Our Team

Felix Feng, MD

Vice Chair for Translational Research, Department of Radiation Oncology; Professor of Radiation Oncology, Urology, and Medicine

Meet Dr. Felix Feng

One comment I always hear from our patients that come back for follow up is how much they miss our team.

Dr. Felix Feng is a radiation oncology leader in translational research. The primary aim of Dr. Feng’s research program is to individualize therapy for patients with aggressive prostate cancer, by identifying determinants of treatment resistance and developing strategies to overcome this resistance.

To enhance current clinical approaches from a biological perspective, his laboratory and dedicated research team are pursuing three major goals: 1) to identify novel molecular biomarkers of aggressive prostate cancer, 2) to understand the mechanisms by which several of these biomarkers drive disease progression, and 3) to develop therapeutic approaches to target these disease drivers.

Dr. Feng serves on the National Cancer Institute Genitourinary Cancer Steering Committee, which oversees and evaluates clinical trials proposed by all national clinical trials cooperative groups. He also serves as Chair of the Biology Scientific Track for the American Society of Radiation Oncology, and as Chair of the Genitourinary Translational Research Program for the RTOG/NRG national cooperative group.

Education

Education

1994-1998 Stanford University BS Distinction and Honors in Biological Sciences
1998-2002 Washington University School of Medicine MD  
2002-2003 Saint Joseph Mercy Hospital, Ypsilanti, Michigan Internship Internal Medicine
2003-2005 University of Michigan Medical Center, Ann Arbor, Department of Radiology Resident Radiology
2005-2006 University of Michigan Medical Center, Ann Arbor, Department of Radiation Oncology Postdoctoral Research Fellow Radiation Biology
2006-2010 University of Michigan Medical Center, Ann Arbor, Department of Radiation Oncology Resident Radiation Oncology
2009-2010 University of Michigan Medical Center, Ann Arbor, Department of Radiation Oncology Chief Resident Radiation Oncology
       
Professional Experience

Professional Experience

  PRINCIPAL POSITIONS HELD    
2013-2016 University of Michigan, Ann Arbor Director, Division of Translational Genomics Radiation Oncology
2010-2016 University of Michigan, Ann Arbor Assistant Professor Radiation Oncology
2016-present University of California, San Francisco Vice Chair for Faculty Development and Translational Research Radiation Oncology
2016-2019 University of California, San Francisco Associate Professor of Radiation Oncology, Urology, and Medicine Radiation Oncology, Urology, and Medicine
2019-present

University of California, San Francisco

Professor of Radiation Oncology, Urology, and Medicine Radiation Oncology, Urology, and Medicine
2019-present

University of California, San Francisco

George and Judy Marcus Distinguished Professor  
2019-present

University of California, San Francisco

Director, Benioff Initiative for Prostate Cancer Research

 
  OTHER POSITIONS HELD CONCURRENTLY    
2010-2016 The University of Michigan Comprehensive Cancer Center Primary: Prostate Cancer Program Secondary: Radiation Sciences Core Member Radiation Oncology
2010-2016 Ann Arbor Veteran’s Health System, Ann Arbor, Michigan Assistant Professor Radiation Oncology
2011-2011 Ann Arbor Veteran’s Health System, Ann Arbor, Michigan Acting Chief Radiation Oncology
2011-2016 University of Michigan Chair Genitourinary Translational Research Program for the NRG/RTOG Cooperative Trials Group
2011-2016 Allegiance Health System, Jackson, Michigan Active Staff Radiation Oncology
2011-2016 Ingham Regional Medical Center, Lansing, Michigan Active Staff Radiation Oncology
2011-2016 Providence Hospital, Southfield, Michigan Active Staff Radiation Oncology
2015-2016 University of Michigan, Ann Arbor Associate Chair for Laboratory Research Radiation Oncology
2010-present NRG/RTOG Cooperative Group Leader Genitourinary Cancer Translational Research Program

Awards & Honors

1994 President’s Scholar for Academic Achievement (for scholastic achievement at Stanford University)
1995 President’s Award for Academic Excellence (for scholastic achievement at Stanford University)
1997 Barry M. Goldwater Fellowship for Excellence in Mathematics, Science, and Engineering (national collegiate award/grant for outstanding basic science research)
1998 Dr. Philip Majerus Distinguished Alumni Scholarship 1998-2002 (full-tuition, four-year merit scholarship at the Washington University School of Medicine, awarded to three students per class)
1999 Washington University Research Award (best summer research project among med students)
2000 American College of Physicians Award for Excellence in Physical Diagnosis
2000 Best Presentation, Midwest Association of Plastic Surgeons Conference
2000 McLaughlin Award, National Student Research Forum (for best presentation in immunology)
2002 Dr. Richard S. Brookings Medical School Prize (awarded for the highest achievement in research among the graduating medical school class)
2002 Missouri State Medical Association Award (for scholastic achievement in medical studies)
2006 Merit award, Translational Research Symposium, ASTRO
2006 First place presentation, Michigan Society of Therapeutic Radiation Oncology (MSTRO) Resident Research Competition
2008 ASTRO Resident Clinical Research Award (for the best abstract submitted by a resident physician to the annual meeting)
2009 Travel grant, Radiation Therapy Oncology Group annual meeting
2009 Resident Scholarship for American Brachytherapy Society/Seattle Prostate Brachytherapy course
2010 Radiological Society of North America Roentgen Resident/Fellow Research Award
2012 American Society of Radiation Oncology Basic Science Award (for the best basic science abstract submitted to the annual meeting of this group)
2014 Teacher of the Year, Radiobiology, Department of Radiation Oncology, University of Michigan
2016 American Society of Radiation Oncology Clinical Science Award (for the best clinical science abstract submitted to the annual meeting of this group)

Redefining Possible